Seoul National University Airway Registry
Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Aug 17, 2015
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
The Seoul National University Airway Registry is a study looking at patients with chronic lung diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and related conditions. The goal is to better understand these diseases and how they affect people over time. This study is currently recruiting participants, and it welcomes individuals of all genders between the ages of 73 and 328 years.
To be eligible for the trial, patients with COPD must have specific breathing challenges and ongoing respiratory symptoms. For those with asthma, they should have had recurrent symptoms and either never smoked or only smoked a little. For participants with both asthma and COPD, having either condition qualifies them for the study. If you decide to join, you can expect to provide information about your health and lung function, which will help researchers learn more about these conditions and improve care for future patients.
Gender
ALL
Eligibility criteria
- • COPD
- Inclusion Criteria:
- • Postbronchodilator FEV1/FVC \< 0.7 AND chronic respiratory symptom
- Exclusion Criteria:
- • -
- • Asthma
- Inclusion Criteria:
- • Never smoker or \<5PY of smoking history AND Recurrent episodes of asthma symptoms (wheezing, dyspnea, chest tightness, cough) AND (either Positive BDR OR positive metacholine/mannitol/exercise provocation test)
- Exclusion Criteria:
- • -
- • ACOS
- Inclusion Criteria:
- • COPD AND Asthma (regardless of smoking status)
- Exclusion Criteria:
- • -
About Seoul National University Hospital
Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Seoul, , Korea, Republic Of
Seongnam, Gyeonggi Do, Korea, Republic Of
Seoul, , Korea, Republic Of
Patients applied
Trial Officials
Chul-Gyu Yoo, M.D.
Study Chair
Seoul National University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials